$2 Billion         |         Rank #1513

Who is Robert Duggan

The success of Pharmacyclics’ cancer drug Imbruvica made him a billionaire in 2013.
Duggan, whose son died from brain cancer, became passionate about Pharmacyclic’s cancer fighting drugs and first invested in 2004.
His enthusiasm for investing began four decades earlier in a corporate finance class he took at the University of California at Santa Barbara.
In 2020, Duggan was appointed CEO and executive chairman of Summit Therapeutics, a small British biotechnology company.
Duggan also sits on the board of Pulse Biosciences, of which he is the largest individual shareholder. Coming from an average or middle class family, Robert Duggan is one those great persons who have stormed their way to the billionaires list on their own. And currently ranks at 1513 on billionaires list making him one of the wealthiest ever persons on the planet. He is currently 77.0 years old. As of today, Robert Duggan’s net worth is approximately 2 Billion.

Facts about Robert Duggan

To find out what is Robert Duggan Net Worth, how he got there and what is Robert Duggan Salary Per Day, Career, Biography and Childhood details, continue reading below.

Background of Robert Duggan

Robert Duggan was born on 28-04-44 in United States. Duggan enjoys surfing in his spare time. Duggan is a big donor to the Church of Scientology, of which he is a member; he says he’s given the church nearly $360 million over his lifetime. Being raised in the same country, Robert Duggan spent most of his time in Florida in the city of Clearwater.

Robert Duggan net worth is estimated at 2 Billion Billion to date.

Professional Journey

You will see him often in social media.  Robert Duggan is a serial entrepreneur; he led the 2015 sale of biotech firm Pharmacyclics to AbbVie for $21 billion in cash and stock There was a time when he would have embraced the change that was coming.  He is one of the persons who are always trending in news. Duggan enjoys surfing in his spare time. In his youth, he was adventurous but unknown, but that was years ago. The success of Pharmacyclics’ cancer drug Imbruvica made him a billionaire in 2013.
Duggan, whose son died from brain cancer, became passionate about Pharmacyclic’s cancer fighting drugs and first invested in 2004.
His enthusiasm for investing began four decades earlier in a corporate finance class he took at the University of California at Santa Barbara.
In 2020, Duggan was appointed CEO and executive chairman of Summit Therapeutics, a small British biotechnology company.
Duggan also sits on the board of Pulse Biosciences, of which he is the largest individual shareholder. He learnt to find the excitement that came with change. That curiosity had long left him to where he had come to loathe anything that put him out of his comfort zone. Robert Duggan is a serial entrepreneur; he led the 2015 sale of biotech firm Pharmacyclics to AbbVie for $21 billion in cash and stock
It is to be noted that Robert Duggan is one of the selfmade billionaires in the world and stands at 1513 in most wealthy persons in the world.

FAQs

Here are a few most frequently asked questions about Robert Duggan:

How much is Robert Duggan worth?

Robert Duggan’s net worth is estimated to be 2 Billion.

How old is Robert Duggan?

Robert Duggan was born on 28-04-44, and is currently 77.0 years old.

What is Robert Duggan source of income?

Robert Duggan acquires most part of his wealth from pharmaceuticals.
 

Concluding Robert Duggan Net Worth

Currently with a net worth of 2 Billion, Robert Duggan stands at 1513 in the world billionaires list. And draws most of his wealth from pharmaceuticals. Hope you like this information about Robert Duggan. If you like this, then please share it with your friends. This above post is all about the estimated worth of Robert Duggan. Do you have any queries? Feel free to ask via comment section.

Disclaimer: Please keep in mind that this is an estimated net worth of Robert Duggan. Actual worth may vary a little. You can always get information by checking out Leaktown.com.